Comparing two drug-coated stents for heart attack patients
Part of Heart & circulation clinical trials.
This trial compares two types of drug-coated stents (one with sirolimus, one with everolimus) in people who have had a heart attack or unstable angina and need a stent. It aims to see which stent works better for new blockages in the heart arteries.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with a heart attack or unstable angina and need a stent procedure.
- The blocked arteries have not been treated before (new blockages) and are suitable for a drug-coated stent.
- You do not have severe low blood pressure (cardiogenic shock).
- You are not allergic to aspirin, blood thinners, or contrast dye.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how different types of drug-coated stents work in everyday care for people with blocked heart arteries. It may help doctors choose the best stent type to keep the artery open after treatment.
This trial compares a newer type of stent (with very thin struts and a coating that dissolves) to a standard stent in people having a heart artery procedure. It aims to see if the new stent works as well or better.
This study looks at how to treat blocked heart arteries that have narrowed again after a prior drug-eluting stent. It compares using another drug-eluting stent versus a drug-coated balloon, chosen based on an imaging scan inside the artery (OCT), to reduce repeat narrowing.
This trial tests whether a drug-coated heart stent (sirolimus with ascorbic acid, a form of vitamin C) works as well as another type (everolimus) for patients with blocked coronary arteries. Both drugs help prevent the stent from becoming blocked again.
This trial compares two types of small mesh tubes (scaffolds and stents) to open blocked heart arteries. It is for people having a specific kind of heart attack or unstable angina who need a stent.
This study follows people who need a coronary (heart) stent to see how they do after treatment. It does not sound like an experimental drug trial for you—it’s mainly about collecting health information after a stent procedure.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.